Gastrointestinal side effects remain among the most frequently cited challenges associated with currently marketed GLP-1 therapies and represent a significant driver of discontinuation
Hash Hashemian, CEO of Analysis and Measurement Services Corporation and President of the American Nuclear Society , in recognition of his outstanding leadership and contributions to advancing STEAM education and nuclear science nationally
Effects of genistein and equol on human and rat testicular 3-hydroxysteroid dehydrogenase and 17-hydroxysteroid dehydrogenase 3 activities
Low energy, low libido, disrupted sleep, and similar concerns may have many possible causes
Todays newsletter, with obesity expert and lecturer in physiology at Anglia Ruskin university Dr Simon Cork, is about what weve just learned, why it changes our understanding of semaglutides and whether it will mean they become more widely available